OriginClear (OCLN) 10-K 29 May 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	May 28, 2020	Jun. 28, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	0001419793
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 1,450,929
Entity Common Stock, Shares Outstanding		9,812,845
Entity File Number	333-147980
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 490,614	$ 609,144
Contracts receivable, less allowance for doubtful accounts of $0 and $6,996 respectively	522,911	309,223
Inventory		13,736
Contract assets	26,287	111,001
Convertible note receivable	117,879	84,900
Other receivable	2,500
Prepaid expenses	47,483	46,584
TOTAL CURRENT ASSETS	1,207,674	1,174,588
NET PROPERTY AND EQUIPMENT	117,069	154,250
OTHER ASSETS
Fair value investment-securities	9,600	22,800
Trademark	4,467	4,467
Security deposit	3,500	3,500
TOTAL OTHER ASSETS	17,567	30,767
TOTAL ASSETS	1,342,310	1,359,605
Current Liabilities
Accounts payable and other payable	1,144,545	987,524
Accrued expenses	1,163,146	1,152,982
Cumulative preferred stock dividends payable	92,472	25,085
Contract liabilities	428,009	112,894
Capital lease, current portion	9,088	9,088
Customer deposit	136,765	120,688
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance, net of finance fees of $0 and $123,458 respectively	427,214	473,507
Loan payable, related party	187,054	219,841
Promissory note, current portion		110
Derivative liabilities	31,640,470	9,360,204
Series F 8% Convertible Preferred Stock, 1,678 and 0 shares issued and outstanding, redeemable value of $1,678,000 and $0, respectively	1,678,000
Convertible promissory notes, net of discount of $0 and $146,005, respectively	2,879,325	1,580,955
Total Current Liabilities	39,806,088	14,062,878
Long Term Liabilities
Capital lease, long term portion	17,073	26,918
Promissory note, long term portion		74,867
Convertible promissory notes, net of discount of $0 and $0, respectively	552,975	2,076,472
Total Long Term Liabilities	3,898,098	2,178,257
Total Liabilities	43,704,186	16,241,135
Series F 8% Convertible Preferred Stock, 0 and 1,743 shares issued and outstanding, redeemable value of $0 and $1,743,000, respectively		1,743,000
COMMITMENTS AND CONTINGENCIES (See Note 12)
SHAREHOLDERS' DEFICIT
Preferred stock value
Additional paid in capital, preferred stock	171,257
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 4,854,993 and 875,244 equity shares issued and outstanding, respectively	486	88
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Additional paid in capital, common stock	64,744,107	63,179,433
Accumulated other comprehensive loss	(134)	(134)
Accumulated deficit	(107,281,659)	(79,807,981)
TOTAL SHAREHOLDERS' DEFICIT	(42,361,876)	(16,624,530)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	1,342,310	1,359,605
Series G Preferred Stock [Member]
Long Term Liabilities
Convertible Preferred Stock	530,000
Series I Preferred Stock [Member]
Long Term Liabilities
Convertible Preferred Stock	797,400
Series K Preferred Stock [Member]
Long Term Liabilities
Convertible Preferred Stock	2,000,650
Series D-1 Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value	3,850	3,850
Series E Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value	214	214
Series J Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock value
Series L Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock value
Series M Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock value	$ 3

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Allowance for doubtful accounts	$ 0	$ 6,996
Merchant cash advances, net of finance fees	0	123,458
Net of discount current	0	146,005
Net of discount non current	$ 0	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common stock, shares issued	4,854,993	875,244
Common stock, shares outstanding	4,854,993	875,244
Preferred treasury stock, shares outstanding	1,000	1,000
Series F 8% Preferred Stock
Convertible preferred stock, redeemable value	$ 1,678,000	$ 0
Convertible preferred stock, share issued	1,678	0
Convertible preferred stock, share outstanding	1,678	0
Convertible preferred stock non current, redeemable value	$ 0	$ 1,743,000
Convertible preferred stock non current, share issued	0	1,743
Convertible preferred stock non current, share outstanding	0	1,743
Series G 8% Preferred Stock
Convertible preferred stock, redeemable value	$ 530,000	$ 0
Convertible preferred stock, share issued	530	530
Convertible preferred stock, share outstanding	530	530
Series I 8% Preferred Stock
Convertible preferred stock, redeemable value	$ 797,400	$ 0
Convertible preferred stock, share issued	797	797
Convertible preferred stock, share outstanding	797	797
Series K 8% Preferred Stock
Convertible preferred stock, redeemable value	$ 2,000,650	$ 0
Convertible preferred stock, share issued	2,001	2,001
Convertible preferred stock, share outstanding	2,001	2,001
Series D-1 Preferred stock
Preferred stock, shares issued	38,500,000	38,500,000
Preferred stock, shares outstanding	38,500,000	38,500,000
Series E Preferred stock
Preferred stock, shares issued	2,139,649	2,139,649
Preferred stock, shares outstanding	2,139,649	2,139,649
Series J Preferred stock
Preferred stock, shares issued	349	349
Preferred stock, shares outstanding	349	349
Series L Preferred stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series M Preferred stock
Preferred stock, shares issued	34,200	34,200
Preferred stock, shares outstanding	34,200	34,200

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Sales	$ 3,587,894	$ 4,637,698
Cost of Goods Sold	3,217,028	3,484,018
Gross Profit	370,866	1,153,680
Operating Expenses
Selling and marketing expenses	1,572,183	1,823,188
General and administrative expenses	2,556,201	3,045,780
Research and development	107,351	290,542
Depreciation and amortization expense	43,369	56,521
Total Operating Expenses	4,279,104	5,216,031
Loss from Operations	(3,908,238)	(4,062,351)
OTHER INCOME (EXPENSE)
Other income	32,980	34,900
Unrealized gain(loss) on investment securities	(13,200)	(7,200)
Realized loss on investment		(39,538)
Loss on sale of asset		(406)
Amortization of financing fees and cost	(165,552)	(35,776)
Gain on settlement of payable	28,428
Loss on settlement of convertible notes	(348,307)
Commitment fee		(479,913)
Loss on conversion of debt	(102,527)	(1,849,979)
Loss on net change in derivative liability and conversion of debt	(22,280,266)	(3,261,137)
Interest expense	(734,624)	(1,645,169)
TOTAL OTHER (EXPENSE) INCOME	(23,565,440)	(7,284,218)
NET INCOME (LOSS)	(27,473,678)	(11,346,569)
PREFERRED STOCK DIVIDENDS		(27,017)
NET LOSS AVAILABLE TO SHAREHOLDERS	$ (27,473,678)	$ (11,373,586)
BASIC AND DILUTED LOSS PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$ (12.66)	$ (50.93)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED	2,170,270	223,334

Consolidated Statement of Share

Consolidated Statement of Shareholders' Deficit - USD ($)	Preferred stock	Additional Paid-in Capital	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive loss	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2017	$ 1		$ 5	$ 58,629,844	$ (134)	$ (68,461,412)	$ (9,831,696)
Beginning balance, shares at Dec. 31, 2017	4,333		456,444
Common stock issuance for conversion of debt and accrued interest			$ 46	2,815,479			2,815,525
Common stock issuance for conversion of debt and accrued interest, shares			457,188
Common stock issued at fair value for services			$ 13	1,207,220			1,207,233
Common stock issued at fair value for services, shares			129,930
Common stock issued thru a private placement for purchase of Series F Preferred stock			$ 22	(22)
Common stock issued thru a private placement for purchase of Series F Preferred stock, shares			215,906
Common stock issued for conversion of Series B Preferred stock	$ (1)
Common stock issued for conversion of Series B Preferred stock, shares	(3,333)		714
Series D Preferred stock issued thru a private placement	$ 1,581			278,419			280,000
Series D Preferred stock issued thru a private placement, shares	15,805,554
Series D Preferred stock converted to Series E Preferred stock	$ (1,581)			(278,419)			(280,000)
Series D Preferred stock converted to Series E Preferred stock, shares	(15,805,554)
Series D-1 Preferred stock issued thru a private placement	$ 3,850			(3,850)
Series D-1 Preferred stock issued thru a private placement, shares	38,500,000
Series E Preferred stock issued thru a private placement	$ 244			506,854			507,098
Series E Preferred stock issued thru a private placement, shares	2,440,871
Series E Preferred stock converted to common stock	$ (30)		$ 2	28
Series E Preferred stock converted to common stock	(301,222)		15,062
Stock compensation cost				50,897			50,897
Cumulative preferred stock dividend				(27,017)			(27,017)
Net loss						(11,346,569)	(11,346,569)
Ending balance at Dec. 31, 2018	$ 4,064		$ 88	63,179,433	(134)	(79,807,981)	(16,624,530)
Ending balance, shares at Dec. 31, 2018	40,640,649		875,244
Common stock issuance for conversion of debt and accrued interest			$ 265	729,001			729,266
Common stock issuance for conversion of debt and accrued interest, shares			2,647,017
Common stock issued at fair value for services			$ 107	706,155			706,262
Common stock issued at fair value for services, shares			1,070,855
Common stock issued thru a private placement for purchase of Series G Preferred stock			$ 8	(8)
Common stock issued thru a private placement for purchase of Series G Preferred stock, shares			82,799
Series J preferred stock converted into common stock			$ 17	(17)
Series J preferred stock converted into common stock, shares	(50)		171,176
Issuance of Series M Preferred stock in exchange for convertible note	$ 3	$ 171,257					171,260
Issuance of Series M Preferred stock in exchange for convertible note, shares	34,200
Common stock reverse split share adjustment			$ 1	(1)
Common stock reverse split share adjustment, shares			7,902
Cumulative preferred stock dividend				27,017			27,017
Loss on conversion of debt				102,527			102,527
Net loss						(27,473,678)	(27,473,678)
Ending balance at Dec. 31, 2019	$ 4,067	$ 171,257	$ 486	$ 64,744,107	$ (134)	$ (107,281,659)	$ (42,361,876)
Ending balance, shares at Dec. 31, 2019	40,674,799		4,854,993

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (27,473,678)	$ (11,346,569)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	43,369	56,521
Common stock and warrants issued for services	706,262	1,207,233
Stock option and warrant compensation expense		50,897
Loss on net change in valuation of derivative liability	22,280,266	3,261,137
Loss on conversion of debt	102,527	1,849,979
Loss on settlement of debt	348,307
Debt discount recognized as interest expense	146,005	660,436
Loss on sale of asset		406
Accrued interest on note receivable	(32,979)
Net unrealized loss on fair value of security	13,200	7,200
Realized loss on security investment		39,538
Exchange of investment for services		80,000
Amortization of financing cost	165,552	35,776
Gain on settlement of payable	(28,428)
Change in Assets (Increase) Decrease in:
Contracts receivable	(213,688)	151,218
Contract asset	84,714	(22,412)
Inventory asset	13,736	(122)
Prepaid expenses and other assets	(899)	15,023
Work in process	(2,500)	84,157
Change in Liabilities Increase (Decrease) in:
Accounts payable	167,821	124,092
Accrued expenses	127,928	317,894
Cumulative preferred stock dividends payable		25,085
Contract liabilities	315,115	(41,154)
Customer deposit	16,077	6,738
Deferred income		(15,500)
NET CASH USED IN OPERATING ACTIVITIES	(3,221,293)	(3,452,427)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Fair value investment - security		(100,000)
Convertible note receivable		(80,000)
Proceeds from sale of asset		2,000
Purchase of fixed assets	(6,188)	(17,109)
CASH USED IN INVESTING ACTIVITIES	(6,188)	(195,109)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(9,845)	(9,434)
Loan payable, truck		(15,699)
Loan payable financing, net	(184,625)	473,507
Loan payable, related party, net		219,841
Promissory note payable, related party		74,977
Payment of cumulative preferred stock dividends		(1,932)
Net cumulative preferred stock dividends payable	40,371
Proceeds from convertible promissory notes		825,500
Payment on redemption of preferred stock	(65,000)
Net proceeds for issuance of preferred stock for cash	3,328,050	2,250,098
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,108,951	3,816,858
NET DECREASE IN CASH	(118,530)	169,322
CASH BEGINNING OF YEAR	609,144	439,822
CASH END OF YEAR	490,614	609,144
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	59,528	155,708
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt and accrued interest	729,266	2,815,525
Capitalized leased asset		45,440
Preferred stock converted to common stock	17
Settlement of derivative	102,527
Issuance of Series M preferred stock for settlement of debt	171,260
Stock issued through private placement	$ 8

Organization and Line of Busine

Organization and Line of Business	12 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. ORGANIZATION AND LINE OF BUSINESS Organization OriginClear, Inc. (the "Company") was incorporated in the state of Nevada on June 1, 2007. The Company, based in Los Angeles, California, began operations on June 1, 2007. The Company began its' planned principle operations in December, 2010, at which time it exited the development stage. In December 2014, the Company formed a wholly owned subsidiary, OriginClear Technologies Limited (OCT), formerly OriginClear (HK) Limited in Hong Kong, China. The Company granted OCT a master license for the People's Republic of China. In turn, OCT is expected to license regional joint ventures for water treatment. As of December 31, 2019, OCT has limited assets and operations. On October 1, 2015, the Company completed the acquisition of 100% of the total issued and outstanding stock of Progressive Water Treatment, Inc. ("PWT") and is included in these consolidated financial statements as a wholly owned subsidiary. On July 19, 2018, the Company announced the launch of its Modular Water Treatment Division. MWS designs, manufactures and implements advanced prepackaged wastewater treatment, pump stations and custom systems with primary focus on decentralized opportunities away from the very competitive large municipal wastewater treatment plants. These decentralized opportunities include: rural communities, housing developments, industrial sites, schools and many more. Line of Business OriginClear is a provider of water treatment solutions and the developer of a breakthrough water cleanup technology. The Company's technology integrates easily with other industry processes and can be embedded into larger systems through licensing and joint ventures. Through the acquisition of Progressive Water Treatment Inc., the Company is primarily engaged in providing water treatment systems and services for a wide variety of applications and component sales. Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the year ended December 31, 2019, the Company did not generate significant revenue, incurred a net loss of $27,473,678 and used cash in operations of $3,188,314. As of December 31, 2019, the Company had a working capital deficiency of $38,598,414 and a shareholders' deficit of $42,361,876. These factors, among others raise substantial doubt about the Company's ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2019 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the year ended December 31, 2019, the Company obtained funds from the issuance of convertible note agreements and from sales of its common stock. Management believes this funding will continue from its' current investors and from new investors. The Company also generated revenue of $3,587,894 and has standing purchase orders and open invoices with customers which will provide funds for operations. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company's obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing. Reverse Stock Split On October 25, 2019, the Company effected a one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the "Reverse Split"). All shares, options, warrants and per share information throughout these consolidated financial statements have been retroactively restated to reflect the Reverse Split.

Summary of Significant Accounti

Summary of Significant Accounting Polices	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company's financial statements. The financial statements and notes are representations of the Company's management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Concentration Risk Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of December 31, 2019, the cash balance in excess of the FDIC limits was $201,007. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company's impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company's diluted loss per share is the same as the basic loss per share for the years ended December 31, 2019 and 2018, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Years Ended 2019 2018 (Loss) to common shareholders (Numerator) $ (27,473,678 ) $ (11,373,586 ) Basic and diluted weighted average number of common shares outstanding denominator 2,170,270 223,334 Year ended December 31, 2019 The Company has excluded 122,044 warrants, shares issuable from convertible debt of $3,432,300 and shares issuable from convertible preferred stock for the year ended December 31, 2019, because their impact on the loss per share is anti-dilutive. Year ended December 31, 2018 The Company has excluded 125,456 warrants, shares issuable from convertible debt of $3,657,427 and shares issuable from convertible preferred stock for the year ended December 31, 2018, because their impact on the loss per share is anti-dilutive. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts were $0 and $6,996 as of December 31, 2019 and 2018, respectively. The net contract receivable balance was $522,911 and $309,223 at December 31, 2019 and 2018, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, "Business Combinations," where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at December 31, 2019 and 2018, and determined there was no impairment of indefinite lived intangibles and goodwill. Research and Development Research and development costs are expensed as incurred. Total research and development costs were $107,351 and $290,542 for the years ended December 31, 2019 and 2018, respectively. Advertising Costs The Company expenses the cost of advertising and promotional materials when incurred. The advertising costs were $48,594 and $103,791 for the years ended December 31, 2019 and 2018, respectively. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years December 31, 2019 2018 Machinery and Equipment $ 193,570 $ 192,330 Computer Equipment 59,468 54,520 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 409,988 403,800 Less accumulated depreciation (292,919 ) (249,550 ) Net Property and Equipment $ 117,069 $ 154,250 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the year ended December 31, 2019 and 2018, respectively was $43,369 and $56,521. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2019, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company's financial assets measured and recorded at fair value on the Company's balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2019 and 2018. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, December 31, 2019 $ 9,600 $ 9,600 $ - $ - Investment at fair value-securities, December 31, 2018 $ 22,800 $ 22,800 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, December 31, 2019 $ 31,640,470 $ - $ - $ 31,640,470 Derivative Liability, December 31, 2018 $ 9,360,204 $ - $ - $ 9,360,204 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2018 $ 5,531,183 Fair Value of derivative liabilities issued 567,884 Loss on conversion of debt and change in derivative liability 3,261,137 Balance as of December 31, 2018 9,360,204 Loss on conversion of debt and change in derivative liability 22,280,266 Balance as of December 31, 2019 $ 31,640,470 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 12/31/2019 12/31/2018 Risk free interest rate 1.48% - 1.69% 2.48% - 2.63% Stock volatility factor 116.0% - 338.0% 136.0% - 396.0% Weighted average expected option life 6 months - 5 years 6 months - 5 years Expected dividend yield None None Segment Reporting The Company's business currently operates in one segment based upon the Company's organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, "Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities." ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor's activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the 'package of practical expedients', which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material impact on the Company's audited consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, "D" (Topic 815) – "Targeted Improvements to Accounting for Hedging Activities", to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company's audited consolidated financial statements, which had no material impact. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – "Shared-Based Payment Arrangements with Nonemployees", which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company's audited consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock Series B On July 31, 2015, the Board of Directors of the Company adopted a Certificate of Designation establishing the rights, preferences, privileges and other terms of Series B Preferred Stock, par value $0.0001 per share which consists of 10,000 shares (the "Series B Preferred Stock"). On October 1, 2015, the Company filed the Certificate of Designation for the Series B Preferred Stock with the Secretary of State of Nevada and Series B Shares were issued to the shareholders of Progressive Water Treatment, Inc. in connection with the share exchange agreement. One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the "Original Issue Date); one third (1/3) may be converted beginning two (2) years after the original issue date; and the remaining one third (1/3) may be converted beginning three years after the original issue date. The number of shares of common stock issuable for each share of converted Series B Preferred Stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice. On August 12, 2016, the agreement was amended to include make-good-shares. The conversion price is to be adjusted to reflect the lower of $2,100 or the price of the Company's Common Stock calculated using the average closing prices of the Company's Common Stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $700 per share, the adjusted conversion price shall be $700 per share. The Series B Preferred Stock has redemption features that are redeemable solely at the option of the Company. Each share of Series B Preferred Stock has a stated value of $150 per share and is convertible into shares of the Company's common stock at a conversion price of $1.05 per share, which may be converted to the Company's common stock in three annual increments beginning 12 months from closing. The conversion price is subject to adjustment in the case of reverse splits, stock dividends, reclassifications and the like. In addition, the conversion price is subject to certain full ratchet anti-dilution protection. Accordingly, the preferred stock is valued under the provision of ASC Topic 815, Derivatives and Hedging, because the conversion feature of the preferred stock was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The Series B Preferred Stock shall have the rights, preferences and privileges as set forth in the exchange agreement. During the year ended December 31, 2019, the Company issued 238 shares of common stock upon conversion of 3,333 shares of preferred stock at a price of $2,100 per share, plus 476 make good shares at a price of $700 per share. As of December 31, 2019, all shares of Series B were converted and no gain or loss was recognized because the transaction occurred within the terms of the agreement. Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. Holder of Series C preferred stock shall not be entitled to receive dividends, shall not be entitled to any liquidation preference and shares of Series C preferred stock shall have no conversion rights. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of December 31, 2019, there are 1,000 shares of Series C preferred stock outstanding. Series D On April 13, 2018, the Board adopted resolutions creating a series of shares of convertible preferred stock designated as 0% Series D preferred stock (the "Series D preferred stock") with a par value of $0.0001. The shares of Series D preferred stock do not have a dividend rate or liquidation preference and do not carry any voting rights. The purchase price shall be $0.02 per unit for an aggregate investment amount of less than $50,000; $0.018 for an aggregate amount of $50,000 or greater, but less than $100,000; $0.016 for an aggregate amount of $100,000 or greater, but less than $250,000; $0.014 for an aggregate amount of $250,000 or greater. At no time may all or a portion of the Series D preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of June 30, 2018, the Company issued 15,805,554 shares of Series D preferred stock through a private placement for a cash value of $280,000 at prices ranging $0.016 to $0.020. During the period ended September 30, 2018, the Series D shares were exchanged for 1,400,000 Series E preferred stock. As of December 31, 2019, there were no outstanding Series D preferred stock. Series D-1 On April 13, 2018, the Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the "Series D-1 preferred stock") with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock have a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible 0.0005 of one share of common stock. The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. The Company issued 38,500,000 preferred shares for services. As of December 31, 2019, there were 38,500,000 shares issued and outstanding. Series E On August 14, 2018, the Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the "Series E preferred stock") with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock, accompanied with five one-hundredths (0.05) warrants each for the purchase of one (1) share of common stock. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. Series F On August 14, 2018, the Company filed a Certificate of Designation for its Series F Convertible preferred stock (the "Series F preferred stock") with the Secretary of State of Nevada designating $2,000,000 units, with each unit consisting of 100 shares of the Company's Series F preferred stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F preferred stock do not have a liquidation preference. Each share of Series F preferred stock is convertible into one share of common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. At no time may all or a portion of the Series F preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of December 31, 2019, there were 1,678 shares of Series F preferred stock issued and outstanding. As of December 31, 2019, the Company accrued dividends in the amount of $33,560. Series G On January 16, 2019, the Company filed a Series G Certificate of Designation with the Nevada Secretary of State (the "Series G Designation"). Pursuant to the Series G Certificate of Designation, the Company may issue up to 6,000 shares of Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser shall receive shares of the Company's common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company's Series G preferred stock for an aggregate purchase price of $530,000, which is recognized as a loan payable. As of December 31, 2019, the Company issued an aggregate of 82,799 shares of its common stock to certain holders of its Series G preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of December 31, 2019, the Company accrued dividends in the amount of $10,600. Series I On April 3, 2019, the Company filed a Series I Certificate of Designation (the "Series I COD") for its Series I Preferred Stock (the "Series I") and a Series J Certificate of designation (the "Series J COD") for its Series J Preferred Stock (the "Series J") with the Nevada Secretary of State. Pursuant to the Series I COD, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. Series J Pursuant to the Series J COD, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company's common stock. The Series J preferred stock is convertible into shares of the Company's common stock, on the terms and conditions set forth in the Series J COD, which includes certain Make-Good Shares for certain holders of the Company's previously disclosed Series F preferred stock and Series G preferred stock. As of December 31, 2019, the Company issued an aggregate of 797 shares of its Series I preferred stock and 349 shares of its Series J preferred stock. As of December 31, 2019, the Company accrued dividends in the amount of $15,948. Series K On June 3, 2019, the Company executed a Series K Certificate of Designation (the "Series K COD") for its Series K Preferred Stock (the "Series K") and a Series L Certificate of designation (the "Series L COD") for its Series L Preferred Stock (the "Series L"). Pursuant to the Series K COD, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. Series L Pursuant to the Series L COD, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company's common stock. The Series L preferred stock is convertible into validly-issued, fully paid and non-assessable shares of the Company's common stock, on the terms and conditions set forth in the Series L COD, which includes certain Make-Good Shares for certain holders of the Company's previously disclosed investment rounds. As of December 31, 2019, the Company issued an aggregate of 2,001 shares of its Series K preferred stock and 1,000 shares of its Series L preferred stock. As of December 31, 2019, the Company accrued dividends in the amount of $32,364. Series M In connection with an exchange agreement (the "Exchange Agreement") with a noteholder of the Company, on December 11, 2019, the Company executed a Series M Certificate of Designation (the "Series M COD") for its Series M Preferred Stock (the "Series M"). Pursuant to the Series M COD, the Company designated 800,000 shares of preferred stock as Series M. The Series M entitles the holders to an annual 10% dividend, payable monthly, on the stated value of $25.00 per share, payable in preference to payment of any dividend on the common stock. Dividends are paid only for shares issued through the private placement. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Series M COD. The Series M has a liquidation preference of $25.00 per share plus any accrued but unpaid dividends, before any payments to holders of common stock. The Series M is convertible into common stock in an amount determined by dividing the stated value being converted by the conversion price. The conversion price is equal to 80% of the average closing price of the common stock for the last five trading days prior to the date the Company receives a conversion notice. The Series M may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The Series M will be redeemable at the option of the Company, after the first anniversary of the original issuance date of the Series M, at a redemption price of $25.00 per share plus any accrued but unpaid dividends. Pursuant to the Exchange Agreement, the Company issued 34,200 shares of newly created Series M Preferred Stock of the Company to the holder in exchange for an outstanding convertible note of the Company in the amount of $171,260 (including accrued interest thereon). No gain or loss was recognized on the exchange of the note. Common Stock On April 23, 2019, the Company filed a certificate of amendment to its articles of incorporation, with the Secretary of the State of Nevada effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 shares from 16,000,000,000. Reverse Stock Split On October 25, 2019, the Company effected a one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the "Reverse Split"). All shares, options, warrants and per share information throughout these consolidated financial statements have been retroactively restated to reflect the Reverse Split. Year ended December 31, 2019 The Company issued 2,647,017 shares of common stock for the settlement of convertible promissory notes in an aggregate principal in the amount of $535,035, plus interest in the amount of $116,306, and a default settlement of $77,925, with an aggregate fair value loss on conversion of debt in the amount of $102,527, based upon conversion prices of $0.05 to $1.84. The Company issued 1,070,855 shares of common stock for services at fair value of $706,262. The Company issued 82,799 shares of common stock through a private placement for purchase of Series G preferred stock. The Company issued 171,176 shares of common stock upon conversion of 50 Series J preferred stock. Year ended December 31, 2018 The Company issued 457,188 shares of common stock for the settlement of convertible promissory notes in an aggregate principal in the amount of $840,138, plus interest in the amount of $125,409, with an aggregate fair value loss on conversion of debt in the amount of $1,849,979, based upon conversion prices of $2.80 to $65.80. The Company issued 129,930 shares of common stock for services at fair value of $1,207,233. The Company issued 215,906 shares of common stock through a private placement for purchase of Series F preferred stock. The Company issued 714 shares of common stock upon conversion of 3,333 Series B preferred stock. The Company issued 15,062 shares of common stock upon conversion of 301,222 Series E preferred stock.

Options and Warrants

Options and Warrants	12 Months Ended
	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
OPTIONS AND WARRANTS	4. OPTIONS AND WARRANTS Restricted Stock to CEO Between May 12, 2016, and August 14, 2019, the Company entered into Restricted Stock Grant Agreements ("the RSGAs") with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares and none have yet vested nor have any been issued. The RSGAs provides for the issuance of up to an aggregate of 109,214 shares of the Company's common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to an aggregate of 54,607 shares of its common stock; b) If the Company's consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization Restricted Stock to Employees and Consultants Between May 12, 2016, and August 14, 2019, the Company entered into Restricted Stock Grant Agreements ("the E&C RSGAs") with its' employees and consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the E&C RSGAs are performance based shares and none have yet vested nor have any been issued. The E&C RSGAs provide for the issuance of up to 378,750 shares of the Company's common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to an aggregate of 189,375 shares of its common stock; b) If the Company's consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and E&C RSGAs to include an alternative vesting schedule for the Grantees. The Grantees can elect to participate in the alternate vesting schedule for grants received at least two years prior to the date requested. On the first day of each calendar month, an aggregate dollar amount of restricted stock equal to an aggregate of 5% of the total dollar amount of the Company's common stock that traded during the prior calendar month, will vest, divided equally among all RSGAs and E&C RSGAs that have duly elected to participate in the alternate vesting schedule, with value based on the fair market value under the respective RSGAs and E&C RSGAs. The fair market value shall equal the average of the trailing ten (10) closing trade prices of the Company's common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company's common stock is then traded. If the fair market value of the Company's common stock on the date the shares are vested is less than the fair market value of the Company's common stock on the effective date of the RSGA or E&C RSGA, then the number of vested shares issuable (assuming all conditions are satisfied) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement. As of December 31, 2019, there was no alternative vesting selected and no shares were issued. Warrants During the years ended December 31, 2019 and 2018, no warrants were issued by the Company. A summary of the Company's warrant activity and related information follows for the years ended December 31, 2019 and 2018: December 31, 2019 December 31, 2018 Weighted Weighted Number average Number average of exercise of exercise Warrants price Warrants price Outstanding - beginning of year 125,456 $ 740 26,781 $ 10,800 Granted - $ - 122,044 $ - Exercised - $ - - $ - Forfeited (3,412 ) $ 240 (23,369 ) $ 180 Outstanding - end of year 122,044 $ 500 125,456 $ 10,800 At December 31, 2019 and 2018, the weighted average remaining contractual life of warrants outstanding: December 31, 2019 December 31, 2018 Weighted Weighted Average Average Remaining Remaining Exercisable Warrants Warrants Contractual Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) Outstanding Exercisable Life (years) $ 240.00 - - - 3,412 3,412 0.42 $ 500.00 122,044 122,044 1.62 122,044 122,044 2.62 122,044 122,044 125,456 125,456 At December 31, 2019, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of December 31, 2019, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 3,432,300 Less current portion 2,879,325 Total long-term liabilities $ 552,975 Maturities of long-term debt for the next four years are as follows: Year Ending December 31, Amount 2020 2,879,325 2021 485,550 2022 - 2023 67,425 $ 3,432,300 At December 31, 2019, the Company had $3,432,300 in convertible promissory notes. On various dates from 2014 through May 2015, the Company issued unsecured convertible promissory notes (the "2014-2015 Notes"), that matured on various dates and were extended sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per annum. The 2014-2015 Notes may be converted into shares of the Company's common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser's option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the year ended December 31, 2019, according to the terms of the agreement, the Company issued 630,466 shares of common stock, upon conversion of $144,450 in principal, plus accrued interest of $66,161, with a fair value loss on settlement of $10,457. As of December 31, 2019, the 2014-2015 Notes had an aggregate remaining balance of $1,100,550. The unsecured convertible promissory notes (the "OID Notes") had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended to June 30, 2018. The OID Notes were convertible into shares of the Company's common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. During the year ended December 31, 2019, according to the terms of the agreement, the Company issued 184,211 shares of common stock upon conversion of principal in the amount of $75,805. The remaining balance as of December 31, 2019, was $67,425. The Company issued various, unsecured convertible promissory notes (the "2015-2016 Notes"), on various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2022. The 2015-2016 Notes bear interest at 10% per annum. The 2015-2016 Notes may be converted into shares of the Company's common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. The remaining balance of the 2015-2016 Notes as of December 31, 2019, was $1,200,000. The Company issued a convertible note (the "Dec 2015 Note") in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company's common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of December 31, 2019, the remaining balance on the Dec 2015 Note was $167,048. The Company issued a convertible note (the "Sep 2016 Note") in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company's common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $187,906 during the year ended December 31, 2019. As of December 31, 2019, the remaining balance on the Sep 2016 Note was $430,896. The Company issued various unsecured convertible promissory notes (the "Jan-Aug 2018 Notes"), in the aggregate amount of $293,000 on various dates from January 24, 2018 thru August 28, 2018. The Jan-Aug 2018 Notes matures on dates from January 24, 2018 thru August 28, 2019. The Jan-Aug 2018 Notes bear interest at 10% per annum. The Jan-Aug 2018 Notes may be converted into shares of the Company's common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion. The conversion feature of the Jan-Aug 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan-Aug 2018 Notes. During the year ended December 31, 2019, according to the terms of the agreement, the Company issued 74,014 shares of common stock, upon conversion of principal in the amount of $81,000, plus accrued interest of $5,903, and a loss on settlement of $40,500, with a fair value loss on conversion of debt in the amount of $99,667. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $42,260 during the year ended December 31, 2019. As of December 31, 2019, the Jan-Aug 2018 Notes were fully converted.   The Company issued two (2) unsecured convertible promissory notes (the "Feb 2018 Notes"), in the aggregate principal amount of $157,500 (each in the amount of $78,750) on February 23, 2018. The Feb 2018 Notes had a maturity date of February 23, 2019, and bear interest at 10% per annum. The first of the two Feb 2018 Notes shall be paid for by the Buyer. The second of the two Feb 2018 Notes shall initially be paid for by the issuance of an offsetting $78,750 secured note issued to the Company by the Buyer. The first of the two notes was funded with cash and the Company must agree to the funding of the second of the two Feb 2018 Notes, before it can be funded with cash. The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company's common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion. The conversion feature of the Feb 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2018 Notes. During the period ended June 30, 2019, the Company entered into a settlement agreement with the investor in the amount of $20,275 (50% of the outstanding balance of $40,550), based on the outstanding balance due and payable under the Notes. During the year ended December 31, 2019, according to the terms of the agreement, the Company issued 76,665 shares of common stock, upon conversion of principal in the amount of $40,550, plus accrued interest of $5,205, and a settlement loss of $20,275, with a fair value loss on conversion of debt of $152,056. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $50,702 during the year ended December 31, 2019. As of December 31, 2019, the Note was fully converted. The Company issued two (2) unsecured convertible promissory notes (the "Apr & May 2018 Notes"), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes mature on April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per annum. The Apr & May 2018 Notes may be converted into shares of the Company's common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but no limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company's common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company's common stock (the "Make-Whole Shares"). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. During the year ended December 31, 2019, according to the terms of the agreement, the Company issued 1,118,394 shares of common stock upon conversion of principal in the amount of $83,930, plus accrued interest of $19,689, with a fair value loss on conversion of debt in the amount of $119,646. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $51,605 during the year ended December 31, 2019. As of December 31, 2019, the remaining balance on the Apr & May 2018 Notes were $466,381. The Company issued an unsecured convertible promissory notes (the "Nov 2018 Note"), in the sum amount of $75,000 on November 30, 2018. The Nov 2018 Note matures on November 30, 2019. The Nov 2018 Note bears interest at 10% per annum. The Nov 2018 Note may be converted into shares of the Company's common stock at a fixed conversion price of $0.05 per share or 50% of the average three (3) lowest trading prices twenty (20) trading days prior to conversion. The conversion feature of the Nov 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the year ended December 31, 2019, according to terms of the agreement, the Company issued 363,229 shares of common stock upon conversion of principal in the amount of $75,000, plus accrued of $4,439, and a settlement loss of $17,150, with a fair value loss on conversion of debt in the amount of $138,078. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $1,438 during the year ended December 31, 2019. The Nov 2018 Note was fully converted as of December 31, 2019. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of December 31, 2019 was $31,640,470.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2019
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	6. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the year ended December 31, 2019 and 2018. Years Ended December 31, 2019 2019 2018 Equipment Contracts $ 2,130,625 $ 3,248,939 Component Sales 959,080 1,187,507 Waste Water Treatment Systems 291,156 - Pump Stations 100,763 - Services Sales 86,270 125,645 Licensing Fees 20,000 75,607 $ 3,587,894 $ 4,637,698 Revenue recognition for other sales arrangements, such as sales for components, service and licensing fees will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the years ending December 31, 2019 and 2018, was $26,287 and $111,001, respectively. The contract liability for the years ended December 31, 2019 and 2018, was $428,009 and $112,894.

Financial Assets

Financial Assets	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	7. FINANCIAL ASSETS Convertible Note Receivable The Company purchased a 10% convertible note in the amount of $80,000, through a private placement with Water Technologies International, Inc ("WTII"). The Note is convertible into common stock of WTII at a price of 65% of the lowest trading price for the ten (10) trading days immediately prior to the conversion date. The conversion price shall not be lower than a price of $0.0001 per share. As of December 31, 2019, the note included principal of $80,000 plus accrued interest of $37,879. Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor's activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of December 31, 2019, the fair value of the preferred shares was $9,600.

Loans Payable

Loans Payable	12 Months Ended
	Dec. 31, 2019
Loans Payable [Abstract]
LOANS PAYABLE	8. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company's assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2019, the finance cost was fully amortized. The term of the loans ranged from two months to six months. The net balance as of December 31, 2019 was $427,214. Promissory Note Payable The Company issued a promissory note on July 18, 2018 for the sum of $75,000. The principal consisted of $67,500 plus a $7,500 origination fee. The interest rate was sixty-nine percent per annum. The monthly payments were $4,318, and the maturity date of the Note was August 1, 2028. The note was personally guaranteed by the Company's CEO. As of September 30, 2019, the note was paid in full. Loan Payable-Related Party The Company's CEO loaned the Company $248,870 as of June 28, 2018. The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates. The funds were used for operating expenses. Principal payments were made in the amount of $32,787, leaving a balance of $187,054 as of December 31, 2019. During the period ended December 31, 2019, the Company recorded interest of $52,877.

Capital Leases

Capital Leases	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
CAPITAL LEASES	9. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the year ended December 31, 2019. The lease is for a sixty (60) month term, with monthly payments of $757 per month, and a purchase option at the end of the lease for $1.00. As of December 31, 2019, the maturities are summarized as follows: Capital lease $ 26,161 Less current portion 9,088 Total long-term liabilities $ 17,073 Long term maturities for the next three years are as follows: Period Ending December 31, 2020 9,088 2021 9,088 2022 7,985 $ 26,161

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the "Act"), which significantly changed U.S. tax law. The Act lowered the Company's U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018. The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2016. Included in the balance at December 31, 2019, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period. The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2019 and 2018, the Company did not recognize interest and penalties. At December 31, 2019, the Company had net operating loss carry-forwards of approximately $41,801,640, which expire at dates that have not been determined. No tax benefit has been reported in the December 31, 2019 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rate to pretax income from continuing operations for the years ended December 31, 2019 and 2018 due to the following: 2019 2018 Book loss $ (5,764,730 ) $ (2,388,460 ) Tax to book differences for deductible expenses 11,360 11,280 Tax non deductible expenses 4,870,700 517,000 Valuation Allowance 882,680 1,860,180 Income tax expense $ - $ - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Net deferred tax liabilities consist of the following components as of December 31, 2019 2018 Deferred tax assets: NOL carryover $ 8,778,350 $ 10,277,800 Other carryovers 728,905 704.420 Deferred tax liabilities: Depreciation (73,755 ) (33,120 ) Less Valuation Allowance (9,433,500 ) (10,949,100 ) Net deferred tax asset $ - $ - Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.

Foreign Subsidiary

Foreign Subsidiary	12 Months Ended
	Dec. 31, 2019
Foreign Subsidiary [Abstract]
FOREIGN SUBSIDIARY	11. FOREIGN SUBSIDIARY On December 31, 2014, the Company formed a wholly owned subsidiary, OriginClear Technologies Limited (OCT), in Hong Kong, China. The Company granted OCT a master license for the People's Republic of China. In turn, OCT is expected to license regional joint ventures for water treatment.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Operating Lease The Company holds an agreement for office space located in Los Angeles, California. The initial agreement was from May 1, 2016 to July 31, 2016 and the term has automatically renewed for successive periods and will continue until terminated in accordance with the agreement. Facility Rental – Related Party The Company rents from its' subsidiary on a month-to-month basis a 12,000 square foot facility in McKinney, Texas at a base rent of $4,850 per month. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for the year ending December 31, 2019. Litigation In February 2019, a Complaint was filed in the Superior Court for the State of California, Case No. 30-2019-01052056-CU-BC-CJC, for breach of contract, common counts for sums due for services allegedly performed, and fraud. The Complaint was filed by RDI Financial, LLC ("RDI"), an assignee of Interdependence, Inc., and named the Company and our developmental subsidiary, WaterChain, Inc., as Defendants. RDI claimed that its assignor, Interdependence, Inc., entered into a contract with the Defendants for Interdependence to provide reputation and professional relationship management services. RDI claimed that Interdependence provided the services and that the Company was required to make certain payments of cash and our capital stock to Interdependence, but did not do so. RDI claims to be entitled to enforce the contract as the assignee, and is demanding monetary damages in the aggregate amount of $630,000. While filed in February, 2019, the Company and WaterChain were unaware of the suit until September of 2019, when they received notice of a default judgment. Litigation counsel was engaged, the absence of prior notice, service of the suit and an improper default promptly challenged, and in October 2019 the Court vacated the default and judgment, and granted the Company and WaterChain leave to file an Answer and Cross-Complaint. Through these filings, the Company and WaterChain, Inc. contest the allegations and claims in the Complaint, and deny that Interdependence performed the required services and contends that we overpaid Interdependence $40,000 for whatever work was done. Specifically, in November, 2019, an Answer was filed denying the claims in the Complaint, along with a Cross-Complaint alleging fraudulent inducement to enter into the contract, negligent misrepresentations, breach of contract, and to rescind the underlying contract. Specifically, we have alleged that Interdependence misrepresented the nature and scope of the services which were to be provided and ability to provide them, misrepresented the results they would obtain from providing such services, and also failed to provide us with the services as required by the contract such that Interdependence was overpaid based on what it in fact did. For those reasons, and prior to any litigation, we terminated the contract for non-performance. On February 6, 2020, the Superior Court set April 4, 2021 as the trial date for this matter. The Company and WaterChain are appropriately defending against the allegations and pursuing affirmative recovery on the cross-complaint. The Company disputes all claims and is appropriately litigating its defenses and pursuing recovery on its cross-suit. The parties are in the preliminary stages of settlement negotiations with the Plaintiff RDI and Interdependence, but we can provide no assurance that any settlement will be reached nor can we provide any assurances regarding any terms of such settlement. As of date of this report, legal fees and costs in this action have been substantial and it is impossible at this time to predict an exact amount, or even a meaningful estimate, of the aggregate sums that may be incurred in finally resolving or adjudicating this lawsuit.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2019
Risks and Uncertainties [Abstract]
CONCENTRATIONS	13. CONCENTRATIONS Major Customers PWT had four major customers for the year ended December 31, 2019. The customers represented 55.60% of billings for the year ending December 31, 2019. The contract receivable balance for the customers was $174,803 at December 31, 2019. PWT had four major customers for the year ended December 31, 2018. The customers represented 68.0% of billings for the year ending December 31, 2018. The contract receivable balance for the customers was $210,365 at December 31, 2018. Major Suppliers PWT had three major vendors for the year ended December 31, 2019. The vendors represented 36.34% of total expenses in the year ending December 31, 2019. The accounts payable balance due to the vendors was $198,733 at December 31, 2019. Management believes no risk is present with the vendors due to other suppliers being readily available. PWT had three major vendors for the year ended December 31, 2018. The vendors represented 41.0% of total expenses in the year ending December 31, 2018. The accounts payable balance due to the vendors was $97,974 at December 31, 2018. Management believes no risk is present with the vendors due to other suppliers being readily available.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	14. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: Between January 3, 2020, and May 14, 2020 holders of convertible promissory notes converted an aggregate principal and interest amount of $94,164 into an aggregate of 2,767,510 shares of the Company's common stock. Between January 2, 2020 and April 24, 2020, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 1,160 shares of the Company's Series K preferred stock for an aggregate purchase price of $1,159,767. The Company also issued an aggregate of 580 shares of its Series L preferred stock to the investors. Between February 25, 2020 and March 5, 2020, holders of Series L Preferred Stock converted an aggregate of 42.5 Series L shares into an aggregate of 875,238 shares, including make-good shares, of the Company's common stock. Between March 5, 2020 and March 25, 2020, holders of Series E Preferred Stock converted an aggregate of 102,436 Series E shares into an aggregate of 30,124 shares, adjusted for the reverse split, of the Company's common stock. Between April 2, 2020 and May 11, 2020, the Company sold an aggregate of 3,904 shares of the Company's Series M preferred stock for an aggregate purchase price of $97,600. Between April 15, 2020 and April 30, 2020, holders of Series M Preferred Stock converted an aggregate of 320 Series M shares into an aggregate of 137,052 shares of the Company's common stock. Between January 16, 2020 and May 21, 2020, the Company issued to consultants and one employee for performance an aggregate of 1,147,928 shares of the Company's common stock for services in lieu of cash considerations including 295,141 shares issued in exchange for 6,000,000 shares of Series D-1 preferred stock. On April 27, 2020, the Company filed a certificate of designation (the "Series O COD") of Series O Preferred Stock (the "Series O") and a certificate of designation (the "Series P COD") of Series P Preferred Stock (the "Series P") with the Secretary of State of Nevada. Pursuant to the Series O COD, the Company designated 2,000 shares of preferred stock as Series O. The Series O have a stated value of $1,000 per share, and are entitled to cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O will not be entitled to any voting rights except as may be required by applicable law. The Series O be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. Pursuant to the Series P COD, the Company designated 500 shares of preferred stock as Series P. The Series P have a stated value of $1,000 per share, and are entitled to receive dividends on an as-converted basis with the Company's common stock. The Series P will vote on an as-converted basis with the common stock, subject, however, to the beneficial ownership limitation set forth in the Series P COD. The Series P are convertible into shares of the Company's common stock, on the terms and conditions set forth in the Series P COD, which includes certain make-good shares for certain prior investors, and provided that, the Series P may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. Between May 4, 2020 and May 5, 2020, the Company received loan proceeds in the aggregate amount of $345,000 (the "PPP Loan") under the Paycheck Protection Program (the "PPP") under the Coronavirus Aid, Relief and Economic Security Act. The principal and accrued interest under the Note is forgivable after eight weeks if the Company uses the PPP Loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and otherwise complies with PPP requirements. In order to obtain forgiveness of the PPP Loan, the Company must submit a request and provide satisfactory documentation regarding its compliance with applicable requirements. The Company must repay any unforgiven principal amount of the Note, with interest, on a monthly basis following the Deferral Period. The Company intends to use the proceeds of the PPP Loan specifically for eligible purposes and to pursue forgiveness, although no assurance is provided that forgiveness for all or any portion of the PPP Loan will be obtained. On May 18, 2020, the Company entered into Restricted Stock Grant Agreements (the "May RSGAs") with its Chief Executive Officer, T. Riggs Eckelberry, members of the Board, employees and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGAs are performance based shares and none have yet vested nor have any been issued. The May RSGAs provide for the issuance of up to an aggregate of 10,500,000 shares of the Company's common stock as follows: 2,000,000 to Mr. Eckelberry, 500,000 to each of the other three members of the Board, and an aggregate of 7,000,000 to employees and consultants provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 5,250,000 shares of its common stock; b) If the Company's consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization),

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Concentration Risk	Concentration Risk Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of December 31, 2019, the cash balance in excess of the FDIC limits was $201,007. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Loss per Share Calculations	Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company's diluted loss per share is the same as the basic loss per share for the years ended December 31, 2019 and 2018, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Years Ended 2019 2018 (Loss) to common shareholders (Numerator) $ (27,473,678 ) $ (11,373,586 ) Basic and diluted weighted average number of common shares outstanding denominator 2,170,270 223,334 Year ended December 31, 2019 The Company has excluded 122,044 warrants, shares issuable from convertible debt of $3,432,300 and shares issuable from convertible preferred stock for the year ended December 31, 2019, because their impact on the loss per share is anti-dilutive. Year ended December 31, 2018 The Company has excluded 125,456 warrants, shares issuable from convertible debt of $3,657,427 and shares issuable from convertible preferred stock for the year ended December 31, 2018, because their impact on the loss per share is anti-dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts were $0 and $6,996 as of December 31, 2019 and 2018, respectively. The net contract receivable balance was $522,911 and $309,223 at December 31, 2019 and 2018, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at December 31, 2019 and 2018, and determined there was no impairment of indefinite lived intangibles and goodwill.
Research and Development	Research and Development Research and development costs are expensed as incurred. Total research and development costs were $107,351 and $290,542 for the years ended December 31, 2019 and 2018, respectively.
Advertising Costs	Advertising Costs The Company expenses the cost of advertising and promotional materials when incurred. The advertising costs were $48,594 and $103,791 for the years ended December 31, 2019 and 2018, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years December 31, 2019 2018 Machinery and Equipment $ 193,570 $ 192,330 Computer Equipment 59,468 54,520 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 409,988 403,800 Less accumulated depreciation (292,919 ) (249,550 ) Net Property and Equipment $ 117,069 $ 154,250 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the year ended December 31, 2019 and 2018, respectively was $43,369 and $56,521.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2019, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company's financial assets measured and recorded at fair value on the Company's balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2019 and 2018. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, December 31, 2019 $ 9,600 $ 9,600 $ - $ - Investment at fair value-securities, December 31, 2018 $ 22,800 $ 22,800 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, December 31, 2019 $ 31,640,470 $ - $ - $ 31,640,470 Derivative Liability, December 31, 2018 $ 9,360,204 $ - $ - $ 9,360,204 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2018 $ 5,531,183 Fair Value of derivative liabilities issued 567,884 Loss on conversion of debt and change in derivative liability 3,261,137 Balance as of December 31, 2018 9,360,204 Loss on conversion of debt and change in derivative liability 22,280,266 Balance as of December 31, 2019 $ 31,640,470 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 12/31/2019 12/31/2018 Risk free interest rate 1.48% - 1.69% 2.48% - 2.63% Stock volatility factor 116.0% - 338.0% 136.0% - 396.0% Weighted average expected option life 6 months - 5 years 6 months - 5 years Expected dividend yield None None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material impact on the Company’s audited consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s audited consolidated financial statements, which had no material impact. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company’s audited consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Schedule of loss per share anti-dilutive effect	For the Years Ended 2019 2018 (Loss) to common shareholders (Numerator) $ (27,451,108 ) $ (11,373,586 ) Basic and diluted weighted average number of common shares outstanding denominator 2,170,270 223,334
Schedule of estimated useful life	Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of property plant and equipment	December 31, 2019 2018 Machinery and Equipment $ 193,570 $ 192,330 Computer Equipment 59,468 54,520 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 409,988 403,800 Less accumulated depreciation (292,919 ) (249,550 ) Net Property and Equipment $ 117,069 $ 154,250
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, December 31, 2019 $ 9,600 $ 9,600 $ - $ - Investment at fair value-securities, December 31, 2018 $ 22,800 $ 22,800 $ - $ -
Schedule of fair value of (liability) financial instruments	Total (Level 1) (Level 2) (Level 3) Derivative Liability, December 31, 2019 $ 31,640,470 $ - $ - $ 31,640,470 Derivative Liability, December 31, 2018 $ 9,360,204 $ - $ - $ 9,360,204
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2018 $ 5,531,183 Fair Value of derivative liabilities issued 567,884 Loss on conversion of debt and change in derivative liability 3,261,137 Balance as of December 31, 2018 9,360,204 Gain on conversion of debt and change in derivative liability 22,280,266 Balance as of December 31, 2019 $ 31,640,470
Schedule of fair market value of derivative liability assumptions	12/31/2019 12/31/2018 Risk free interest rate 1.48% - 1.69% 2.48% - 2.63% Stock volatility factor 116.0% - 338.0% 136.0% - 396.0% Weighted average expected option life 6 months - 5 years 6 months - 5 years Expected dividend yield None None

Options and Warrants (Tables)

Options and Warrants (Tables)	12 Months Ended
	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
Schedule of warrant activity	December 31, 2019 December 31, 2018 Weighted Weighted Number average Number average of exercise of exercise Warrants price Warrants price Outstanding - beginning of year 125,456 $ 740 26,781 $ 10,800 Granted - $ - 122,044 $ - Exercised - $ - - $ - Forfeited (3,412 ) $ 240 (23,369 ) $ 180 Outstanding - end of year 122,044 $ 500 125,456 $ 10,800
Schedule of weighted average remaining contractual life of warrants outstanding	December 31, 2019 December 31, 2018 Weighted Weighted Average Average Remaining Remaining Exercisable Warrants Warrants Contractual Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) Outstanding Exercisable Life (years) $ 240.00 - - - 3,412 3,412 0.42 $ 500.00 122,044 122,044 1.62 122,044 122,044 2.62 122,044 122,044 125,456 125,456

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes $ 3,432,300 Less current portion 2,879,325 Total long-term liabilities $ 552,975
Schedule of maturities of long-term debt	Year Ending December 31, Amount 2020 2,879,325 2021 485,550 2022 - 2023 67,425 $ 3,432,300

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2019
Revenue from Contracts with Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Years Ended December 31, 2019 2019 2018 Equipment Contracts $ 2,130,625 $ 3,248,939 Component Sales 959,080 1,187,507 Waste Water Treatment Systems 291,156 - Pump Stations 100,763 - Services Sales 86,270 125,645 Licensing Fees 20,000 75,607 $ 3,587,894 $ 4,637,698

Capital Leases (Tables)

Capital Leases (Tables)	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Schedule of maturities	Capital lease $ 26,161 Less current portion 9,088 Total long-term liabilities $ 17,073
Schedule of long term maturities	Period Ending December 31, 2020 9,088 2021 9,088 2022 7,985 $ 26,161

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of income tax provision	2019 2018 Book loss $ (5,764,730 ) $ (2,388,460 ) Tax to book differences for deductible expenses 11,360 11,280 Tax non deductible expenses 4,870,700 517,000 Valuation Allowance 882,680 1,860,180 Income tax expense $ - $ -
Schedule of net deferred tax liabilities	2019 2018 Deferred tax assets: NOL carryover $ 8,778,350 $ 10,277,800 Other carryovers 728,905 704.420 Deferred tax liabilities: Depreciation (73,755 ) (33,120 ) Less Valuation Allowance (9,433,500 ) (10,949,100 ) Net deferred tax asset $ - $ -

Organization and Line of Busi_2

Organization and Line of Business (Details) - USD ($)	1 Months Ended	12 Months Ended
	Oct. 25, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Oct. 01, 2015
Organization and Line of Business (Textual)
Net loss		$ (27,473,678)	$ (11,346,569)
Net cash used in operations		(3,221,293)	(3,452,427)
Shareholders' deficit		(42,361,876)	$ (16,624,530)	$ (9,831,696)
Revenue		3,587,894
Working capital deficiency		$ 38,598,414
Reverse stock split, description	The Company effected a one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the "Reverse Split"). All shares, options, warrants and per share information throughout these consolidated financial statements have been retroactively restated to reflect the Reverse Split.
Progressive Water Treatment, Inc. [Member]
Organization and Line of Business (Textual)
Percentage of stock issued and outstanding acquired					100.00%

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Schedule of loss per share anti-dilutive effect
(Loss) to common shareholders (Numerator)	$ (27,473,678)	$ (11,373,586)
Basic and diluted weighted average number of common shares outstanding denominator	2,170,270	223,334

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details 1)	12 Months Ended
	Dec. 31, 2019
Machinery and Equipment [Member] | Minimum [Member]
Schedule of estimated useful life
Estimated Life	5 years
Machinery and Equipment [Member] | Maximum [Member]
Schedule of estimated useful life
Estimated Life	10 years
Furniture, Fixtures and Computer Equipment [Member] | Minimum [Member]
Schedule of estimated useful life
Estimated Life	5 years
Furniture, Fixtures and Computer Equipment [Member] | Maximum [Member]
Schedule of estimated useful life
Estimated Life	7 years
Vehicles [Member] | Minimum [Member]
Schedule of estimated useful life
Estimated Life	3 years
Vehicles [Member] | Maximum [Member]
Schedule of estimated useful life
Estimated Life	5 years
Leasehold Improvements [Member] | Minimum [Member]
Schedule of estimated useful life
Estimated Life	2 years
Leasehold Improvements [Member] | Maximum [Member]
Schedule of estimated useful life
Estimated Life	5 years

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details 2) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Schedule of Property and Equipment
Less accumulated depreciation	$ (292,919)	$ (249,550)
Net Property and Equipment	117,069	154,250
Machinery and Equipment [Member]
Schedule of Property and Equipment
Gross Property and Equipment	193,570	192,330
Computer Equipment [Member]
Schedule of Property and Equipment
Gross Property and Equipment	59,468	54,520
Furniture [Member]
Schedule of Property and Equipment
Gross Property and Equipment	29,810	29,810
Leasehold Improvements [Member]
Schedule of Property and Equipment
Gross Property and Equipment	26,725	26,725
Vehicles [Member]
Schedule of Property and Equipment
Gross Property and Equipment	64,276	64,276
Demo Units [Member]
Schedule of Property and Equipment
Gross Property and Equipment	$ 36,139	$ 36,139

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details 3) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	$ 9,600	$ 22,800
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	9,600	22,800
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details 4) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Schedule of fair value of financial instruments
Derivative Liability	$ 31,640,470	$ 9,360,204
Level 1 [Member]
Schedule of fair value of financial instruments
Derivative Liability
Level 2 [Member]
Schedule of fair value of financial instruments
Derivative Liability
Level 3 [Member]
Schedule of fair value of financial instruments
Derivative Liability	$ 31,640,470	$ 9,360,204

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details 5) - Fair Value, Inputs, Level 3 [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Schedule of reconciliation of the derivative liability for which Level 3 inputs
Beginning balance	$ 9,360,204	$ 5,531,183
Fair Value of derivative liabilities issued		567,884
Loss on conversion of debt and change in derivative liability		3,261,137
Gain on conversion of debt and change in derivative liability	22,280,266
Ending balance	$ 31,640,470	$ 9,360,204

Summary of Significant Accou_10

Summary of Significant Accounting Polices (Details 6) - Derivative [Member]	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Schedule of fair market value of derivative liability assumptions
Expected dividend yield
Minimum [Member]
Schedule of fair market value of derivative liability assumptions
Risk free interest rate	1.48%	2.48%
Stock volatility factor	116.00%	136.00%
Weighted average expected option life	6 months	6 months
Maximum [Member]
Schedule of fair market value of derivative liability assumptions
Risk free interest rate	1.69%	2.63%
Stock volatility factor	338.00%	396.00%
Weighted average expected option life	5 years	5 years

Summary of Significant Accou_11

Summary of Significant Accounting Polices (Details Textual)	12 Months Ended
	Dec. 31, 2019USD ($)Vendorsshares	Dec. 31, 2018USD ($)shares
Summary of Significant Accounting Polices (Textual)
Federal deposit insurance amount	$ 201,007
Allowance for doubtful accounts	0	$ 6,996
Contract receivable	522,911	309,223
Total research and development costs	107,351	290,542
Advertising costs	48,594	103,791
Depreciation expense	$ 43,369	$ 56,521
Number of segment reporting | Vendors	1
Convertible Debt [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share | shares	3,432,300	3,657,427
Warrant [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share | shares	122,044	125,456

Capital Stock (Details)

Capital Stock (Details) - USD ($)

Dec. 11, 2019

Jun. 03, 2019

Apr. 03, 2019

Aug. 14, 2018

Apr. 13, 2018

Mar. 14, 2017

Oct. 01, 2015

Oct. 25, 2019

Oct. 25, 2019

Jan. 16, 2019

Dec. 27, 2018

Sep. 30, 2018

Dec. 31, 2019

Dec. 31, 2018

Jun. 30, 2018

Jul. 31, 2015

Capital Stock (Textual)

Preferred stock, par value

$ 1,000

Series D Preferred stock issued through a private placement

$ 280,000

Preferred stock, shares authorized

550,000,000

550,000,000

Common stock, shares authorized

16,000,000,000

16,000,000,000

Description of reverse split

The Company effected a one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the "Reverse Split"). All shares, options, warrants and per share information throughout these consolidated financial statements have been retroactively restated to reflect the Reverse Split.

Issuance of Series M preferred stock for settlement of debt

$ 171,260

Common Stock [Member]

Capital Stock (Textual)

Issuance of common stock, shares

Series D Preferred stock issued through a private placement

Common stock for settlement of convertible promissory notes

2,647,017

457,188

Aggregate principal amount

$ 535,035

$ 840,138

Interest amount

$ 116,306

$ 125,409

Common stock issued for services, shares

1,070,855

129,930

Common stock issued for services

$ 706,262

$ 1,207,233

Fair value loss on settlement

77,925

1,849,979

Debt conversion amount

$ 102,527

$ 1,849,979

Description of reverse split

one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the "Reverse Split").

Issuance of series M preferred stock shares

Maximum [Member] | Common Stock [Member]

Capital Stock (Textual)

Conversion price

$ 1.84

$ 65.80

Minimum [Member] | Common Stock [Member]

Capital Stock (Textual)

Conversion price

$ 0.05

$ 2.80

Series E Preferred Stock [Member]

Capital Stock (Textual)

Preferred stock, shares outstanding

2,139,649

2,139,649

Issuance of common stock, shares

15,062

Common stock for settlement of convertible promissory notes

15,062

301,222

Description of convertible preferred stock terms

The Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the "Series E preferred stock") with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock, accompanied with five one-hundredths (0.05) warrants each for the purchase of one (1) share of common stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. On August 14, 2018, the Company sold 1,040,871 shares of Series E preferred stock for $227,098. Also, on August 14, 2018, the Series D shares were cancelled and exchanged for 1,400,000 shares of Series E, for a total aggregate of 2,440,871 shares of Series E preferred stock.

Series B Preferred Stock [Member]

Capital Stock (Textual)

Stock conversion basis, description

One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the "Original Issue Date); one third (1/3) may be converted beginning two (2) years after the original issue date; and the remaining one third (1/3) may be converted beginning three years after the original issue date. The number of shares of common stock issuable for each share of converted Series B Preferred Stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice. On August 12, 2016, the agreement was amended to include make-good-shares. The conversion price is to be adjusted to reflect the lower of $2,100 or the price of the Company's Common Stock calculated using the average closing prices of the Company's Common Stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $700 per share, the adjusted conversion price shall be $700 per share.

Preferred stock, shares issued

10,000

Preferred stock, par value

$ 150

$ 0.0001

Conversion price

$ 1.05

Conversion of stock, description

The Company issued 238 shares of common stock upon conversion of 3,333 shares of preferred stock at a price of $2,100 per share, plus 476 make good shares at a price of $700 per share. As of December 31, 2019, all shares of Series B were converted.

Issuance of common stock, shares

714

Common stock for settlement of convertible promissory notes

3,333

Series C Preferred Stock [Member]

Capital Stock (Textual)

Preferred stock, par value

$ 0.0001

Preferred stock, shares outstanding

1,000

Purchase price of the Series C preferred stock

$ 0.10

Total purchase price Series C preferred stock, shares

1,000

Series C Preferred Stock [Member] | President [Member]

Capital Stock (Textual)

Preferred stock, shares issued

1,000

Preferred stock, par value

$ 0.0001

Series D Preferred Stock [Member]

Capital Stock (Textual)

Preferred stock, shares issued

15,805,554

Description of convertible preferred stock terms

The Board adopted resolutions creating a series of shares of convertible preferred stock designated as 0% Series D preferred stock (the "Series D preferred stock") with a par value of $0.0001. The shares of Series D preferred stock do not have a dividend rate or liquidation preference and do not carry any voting rights. The purchase price shall be $0.02 per unit for an aggregate investment amount of less than $50,000; $0.018 for an aggregate amount of $50,000 or greater, but less than $100,000; $0.016 for an aggregate amount of $100,000 or greater, but less than $250,000; $0.014 for an aggregate amount of $250,000 or greater. At no time may all or a portion of the Series D preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion.

Cash value

$ 280,000

Exchanged for Series E preferred stock

1,400,000

Series D Preferred Stock [Member] | Maximum [Member]

Capital Stock (Textual)

Conversion price

$ 0.020

Series D Preferred Stock [Member] | Minimum [Member]

Capital Stock (Textual)

Conversion price

$ 0.016

Series D One Preferred Stock [Member]

Capital Stock (Textual)

Preferred stock, shares outstanding

38,500,000

38,500,000

Description of convertible preferred stock terms

The Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the "Series D-1 preferred stock") with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock have a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible 0.0005 of one share of common stock. The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. The Company issued 38,500,000 preferred shares for services. As of December 31, 2019, there were 38,500,000 shares issued and outstanding.

Series J Preferred Stock [Member]

Capital Stock (Textual)

Preferred stock, shares outstanding

349

349

Issuance of common stock, shares

171,176

Common stock for settlement of convertible promissory notes

50

Description of convertible preferred stock terms

Pursuant to the Series J COD, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed Series F preferred stock and Series G preferred stock. As of December 31, 2019, the Company issued an aggregate of 797 shares of its Series I preferred stock and 349 shares of its Series J preferred stock. As of December 31, 2019, the Company accrued dividends in the amount of $15,948.

Series F Preferred Stock [Member]

Capital Stock (Textual)

Issuance of common stock, shares

215,906

Description of convertible preferred stock terms

The Company filed a Certificate of Designation for its Series F Convertible preferred stock (the "Series F preferred stock") with the Secretary of State of Nevada designating $2,000,000 units, with each unit consisting of 100 shares of the Company's Series F preferred stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F preferred stock do not have a liquidation preference. Each share of Series F preferred stock is convertible into one share of common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. At no time may all or a portion of the Series F preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of December 31, 2019, there were 1,678 shares of Series F preferred stock issued and outstanding. As of December 31, 2019, the Company accrued dividends in the amount of $33,560.

Convertible preferred stock, share issued

1,678

0

Series G Preferred Stock [Member]

Capital Stock (Textual)

Issuance of common stock, shares

82,799

Description of convertible preferred stock terms

The Company filed a Series G Certificate of Designation with the Nevada Secretary of State (the “Series G Designation”). Pursuant to the Series G Certificate of Designation, the Company may issue up to 6,000 shares of Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser shall receive shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company’s Series G preferred stock for an aggregate purchase price of $530,000, which is recognized as a loan payable. As of December 31, 2019, the Company issued an aggregate of 82,799 shares of its common stock to certain holders of its Series G preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of December 31, 2019, the Company accrued dividends in the amount of $10,600.

Convertible preferred stock, share issued

530

530

Series I Preferred Stock [Member]

Capital Stock (Textual)

Description of convertible preferred stock terms

The Company filed a Series I Certificate of Designation (the “Series I COD”) for its Series I Preferred Stock (the “Series I”) and a Series J Certificate of designation (the “Series J COD”) for its Series J Preferred Stock (the “Series J”) with the Nevada Secretary of State. Pursuant to the Series I COD, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense.

Convertible preferred stock, share issued

797

797

Series K Preferred Stock [Member]

Capital Stock (Textual)

Description of convertible preferred stock terms

The Company executed a Series K Certificate of Designation (the “Series K COD”) for its Series K Preferred Stock (the “Series K”) and a Series L Certificate of designation (the “Series L COD”) for its Series L Preferred Stock (the “Series L”). Pursuant to the Series K COD, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense.

Convertible preferred stock, share issued

2,001

2,001

Series L Preferred Stock [Member]

Capital Stock (Textual)

Description of convertible preferred stock terms

Pursuant to the Series L COD, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into validly-issued, fully paid and non-assessable shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed investment rounds. As of December 31, 2019, the Company issued an aggregate of 2,001 shares of its Series K preferred stock and 1,000 shares of its Series L preferred stock. As of December 31, 2019, the Company accrued dividends in the amount of $32,364.

Series M Preferred Stock [Member]

Capital Stock (Textual)

Preferred stock, shares outstanding

34,200

34,200

Description of convertible preferred stock terms

The Company executed a Series M Certificate of Designation (the “Series M COD”) for its Series M Preferred Stock (the “Series M”). Pursuant to the Series M COD, the Company designated 800,000 shares of preferred stock as Series M. The Series M entitles the holders to an annual 10% dividend, payable monthly, on the stated value of $25.00 per share, payable in preference to payment of any dividend on the common stock. Dividends are paid only for shares issued through the private placement. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Series M COD. The Series M has a liquidation preference of $25.00 per share plus any accrued but unpaid dividends, before any payments to holders of common stock. The Series M is convertible into common stock in an amount determined by dividing the stated value being converted by the conversion price. The conversion price is equal to 80% of the average closing price of the common stock for the last five trading days prior to the date the Company receives a conversion notice. The Series M may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The Series M will be redeemable at the option of the Company, after the first anniversary of the original issuance date of the Series M, at a redemption price of $25.00 per share plus any accrued but unpaid dividends.

Convertible preferred stock, share issued

34,200

Convertible preferred stock, value issued

$ 171,260

Issuance of series M preferred stock shares

34,200

Issuance of Series M preferred stock for settlement of debt

$ 171,260

Options and Warrants (Details)

Options and Warrants (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Number of Warrants
Outstanding - beginning of year	125,456	26,781
Granted		122,044
Exercised
Forfeited	(3,412)	(23,369)
Outstanding - end of year	122,044	125,456
Weighted average exercise price
Outstanding - beginning of year	$ 740	$ 10,800
Granted
Exercised
Forfeited	240	180
Outstanding - end of year	$ 500	$ 740

Options and Warrants (Details 1

Options and Warrants (Details 1) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrants Outstanding	122,044	125,456
Warrants Exercisable	122,044	125,456
240.00 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercisable Prices	$ 240	$ 240
Warrants Outstanding		3,412
Warrants Exercisable		3,412
Weighted Average Remaining Contractual Life (years)	0 years	5 months 1 day
500.00 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercisable Prices	$ 500	$ 500
Warrants Outstanding	122,044	122,044
Warrants Exercisable	122,044	122,044
Weighted Average Remaining Contractual Life (years)	1 year 7 months 13 days	2 years 7 months 13 days

Options and Warrants (Details T

Options and Warrants (Details Textual) - USD ($)	Aug. 14, 2019	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of shares		30,250
Warrants outstanding		$ 0
Chief Executive Officer [Member] | Restricted Stock Grant Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock, shares	109,214
Restricted stock grant agreement, description	The Company's common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to an aggregate of 54,607 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to an aggregate of 54,607 shares of its common stock.
Consultant And Employee Rsga [Member] | Restricted Stock Grant Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock, shares	378,750
Fair market value of stock grant, description	The Grantees can elect to participate in the alternate vesting schedule for grants received at least two years prior to the date requested. On the first day of each calendar month, an aggregate dollar amount of restricted stock equal to an aggregate of 5% of the total dollar amount of the Company's common stock that traded during the prior calendar month, will vest, divided equally among all RSGAs and E&C RSGAs that have duly elected to participate in the alternate vesting schedule, with value based on the fair market value under the respective RSGAs and E&C RSGAs. The fair market value shall equal the average of the trailing ten (10) closing trade prices of the Company's common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company's common stock is then traded.
Restricted stock grant agreement, description	The Company's common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to an aggregate of 189,375 shares of its common stock; b) If the Company's consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to an aggregate of 189,375 shares of its common stock.

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Convertible Promissory Notes	$ 3,432,300
Less current portion	2,879,325	$ 1,580,955
Total long-term liabilities	$ 552,975

Convertible Promissory Notes _2

Convertible Promissory Notes (Details 1)	Dec. 31, 2019USD ($)
Maturities of long-term debt
2020	$ 2,879,325
2021	485,550
2022
2023	67,425
Total	$ 3,432,300

Convertible Promissory Notes _3

Convertible Promissory Notes (Details Textual) - USD ($)	1 Months Ended		6 Months Ended	7 Months Ended	12 Months Ended
	Nov. 30, 2018	Feb. 23, 2018	Jun. 30, 2019	Aug. 28, 2018	Dec. 31, 2019	Dec. 31, 2018	Jun. 28, 2018
Convertible Promissory Notes (Textual)
Convertible promissory notes					$ 552,975	$ 2,076,472
Net balance							$ 248,870
Derivative liability					31,640,470	$ 9,360,204
Recognized interest expense					$ 42,260
Unsecured Convertible Notes Three [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Additional notes issuance		$ 78,750
Converted an aggregate principal amount		157,500			$ 40,550
Number of shares converted into common stock					76,665
Aggregate remaining amount					$ 40,550
Recognized interest expense					50,702
Accrued interest					$ 5,205
Conversion price per share of debt, description					The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company's common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion.
Fair value loss on convertible debt					$ 152,056
Fair value loss on settlement			$ 20,275		$ 20,275
Aggregate principal each amount		$ 78,750
Notes maturity date					Feb. 23, 2019
Unsecured Convertible Notes Two [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount				$ 293,000
Number of shares converted into common stock					74,014
Aggregate remaining amount					$ 81,000
Accrued interest					$ 5,903
Conversion price per share of debt, description					The Company's common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion.
Fair value loss on convertible debt					$ 99,667
Fair value loss on settlement					$ 40,500
Unsecured Convertible Notes Five [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount	$ 75,000				$ 75,000
Recognized interest expense					1,438
Accrued interest					$ 4,439
Conversion price per share of debt, description					50% of the average three (3) lowest trading prices twenty (20) trading days prior to conversion.
Fair value loss on convertible debt					$ 138,078
Fair value loss on settlement					$ 17,150
Unsecured Convertible Notes Four [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount					$ 466,381
Reserved shares					2,630,769
Aggregate remaining amount					$ 83,930
Recognized interest expense					51,605
Accrued interest					$ 51,605
Description of debt instrument					The Company issued 1,118,394 shares of common stock upon conversion of principal in the amount of $83,930, plus accrued interest of $19,689, with a fair value loss on conversion of debt in the amount of $119,646. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $51,605 during the year ended December 31, 2019. As of December 31, 2019, the remaining balance on the Apr & May 2018 Notes were $466,381.
Conversion price per share of debt, description					The Apr & May 2018 Notes bear interest at 10% per annum. The Apr & May 2018 Notes may be converted into shares of the Company's common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty five (25) trading days prior to conversion.
Fair value loss on convertible debt					$ 119,646
Unsecured Convertible Notes One [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Aggregate remaining amount					$ 1,200,000
Conversion price per share of debt, description					50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes.
OID Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument, maturity date					Dec. 31, 2017
Aggregate remaining amount					$ 184,124
Accrued interest					$ 13,334
Conversion price of debt					$ 5,600
Conversion price per share of debt, description					After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Convertible Debt [Member]
Convertible Promissory Notes (Textual)
Aggregate remaining amount					$ 167,048
Description of debt instrument					Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of December 31, 2019, the remaining balance on the Dec 2015 Note was $167,048.
Conversion price per share of debt, description					The Company issued 184,211 shares of common stock upon conversion of principal in the amount of $75,805. The remaining balance as of December 31, 2019, was $67,425.
Conversion of accounts payable into a convertible note					$ 432,048
Percentage of average of lowest closing prices					75.00%
Number of trading days previous to conversion					25 days
Fair value loss on settlement					$ 245,496
Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Convertible promissory notes					3,432,300
Remaining debt discount					146,005
Net balance					$ 3,657,427
Debt instrument interest rate					10.00%
Converted an aggregate principal amount					$ 144,450
Number of shares converted into common stock					630,466
Derivative liability					$ 430,896
Aggregate remaining amount					1,100,550
Accrued interest					$ 66,161
Conversion price per share of debt, description					50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes.
Fair value loss on settlement					$ 10,457
Convertible Debt One [Member]
Convertible Promissory Notes (Textual)
Recognized interest expense					$ 187,906
Description of debt instrument					Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note					$ 430,896

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue from Contracts with Customers [Abstract]
Equipment Contracts	$ 2,130,625	$ 3,248,939
Component Sales	959,080	1,187,507
Waste Water Treatment Systems	291,156
Pump Stations	100,763
Services Sales	86,270	125,645
Licensing Fees	20,000	75,607
Total	$ 3,587,894	$ 4,637,698

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details Textual) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Revenue from Contracts with Customers (Textual)
Contract assets	$ 26,287	$ 111,001
Contract liability	$ 428,009	$ 112,894

Financial Assets (Details)

Financial Assets (Details) - USD ($)	May 15, 2018	Dec. 31, 2019	Dec. 31, 2018
Financial Assets (Textual)
Financial asset, description	The Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance.
Preferred shares fair value		$ 9,600	$ 22,800
Notes Receivable [Member]
Financial Assets (Textual)
Convertible note percentage		10.00%
Convertible note amount		$ 80,000
Convertible note price		65.00%
Conversion price per share		$ 0.0001
Convertible note principal amount		$ 80,000
Convertible note accrued interest		$ 37,879

Loans Payable (Details)

Loans Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 28, 2018
Loans Payable (Textual)
Loan payable, net	$ 427,214	$ 473,507
Maturity date, description	The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates.
Payments balance	$ 187,054	$ 219,841
Principal amount	32,787
Notes payable			$ 248,870
Interest payable	$ 52,877
Secured Loans Payable [Member]
Loans Payable (Textual)
Description of debt instrument	Short term loans with various lenders for capital expansion secured by the Company's assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans ranged from two months to six months.
Promissory Note Payable [Member]
Loans Payable (Textual)
Description of debt instrument	Promissory note on July 18, 2018 for the sum of $75,000. The principal consisted of $67,500 plus a $7,500 origination fee. The interest rate was sixty-nine percent per annum. The monthly payments were $4,318, and the maturity date of the Note was August 1, 2028. The note was personally guaranteed by the Company's CEO. As of September 30, 2019, the note was paid in full.

Capital Leases (Details)

Capital Leases (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Capital lease	$ 26,161
Less current portion	9,088
Total long-term liabilities	$ 17,073	$ 26,918

Capital Leases (Details 1)

Capital Leases (Details 1)	Dec. 31, 2019USD ($)
Leases [Abstract]
2020	$ 9,088
2021	9,088
2022	7,985
Total	$ 26,161

Capital Leases (Details Textual

Capital Leases (Details Textual)	12 Months Ended
	Dec. 31, 2019USD ($)$ / shares
Capital Leases (Textual)
Capital lease term	60 months
Lease price | $ / shares	$ 1
Monthly payments for lease | $	$ 757

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Book loss	$ (5,764,730)	$ (2,388,460)
Tax to book differences for deductible expenses	11,360	11,280
Tax non deductible expenses	4,870,700	517,000
Valuation Allowance	882,680	1,860,180
Income tax expense

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets:
NOL carryover	$ 8,778,350	$ 10,277,800
Other carryovers	728,905	704,420
Deferred tax liabilities:
Depreciation	(73,755)	(33,120)
Less Valuation Allowance	(9,433,500)	(10,949,100)
Net deferred tax asset

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	1 Months Ended
	Jan. 31, 2018	Dec. 31, 2019
Income Taxes (Textual)
Net operating loss carry-forwards		$ 41,801,640
Minimum [Member]
Income Taxes (Textual)
U.S. statutory federal income tax rate	35.00%
Maximum [Member]
Income Taxes (Textual)
U.S. statutory federal income tax rate	21.00%

Commitments and Contingencies (

Commitments and Contingencies (Details)	12 Months Ended
	Dec. 31, 2019USD ($)ft²	Feb. 28, 2019USD ($)
Commitments and Contingencies (Textual)
Warrant reserve	$ 20,000
Aggregate amount demanding monetary damages		$ 630,000
Services amount overpaid		$ 40,000
Convertible promissory note	$ 3,432,300
Mckinney [Member]
Commitments and Contingencies (Textual)
Area of land | ft²	12,000
Base rent	$ 4,850

Concentrations (Details)

Concentrations (Details)	12 Months Ended
	Dec. 31, 2019USD ($)CustomersVendors	Dec. 31, 2018USD ($)CustomersVendors
Customers [Member]
Concentrations (Textual)
Contract receivable	$ 174,803	$ 210,365
Percentage of billings	55.60%	68.00%
Number of customers | Customers	4	4
Vendors [Member]
Concentrations (Textual)
Accounts payable	$ 198,733	$ 97,974
Percentage of total expenses	36.34%	41.00%
Number of vendors | Vendors	3	3

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

May 18, 2020

May 05, 2020

Mar. 05, 2020

Apr. 03, 2019

May 11, 2020

May 05, 2020

Apr. 30, 2020

Apr. 27, 2020

Apr. 24, 2020

Mar. 25, 2020

Apr. 24, 2019

Apr. 23, 2019

Apr. 19, 2019

Apr. 17, 2019

May 21, 2020

May 14, 2020

Apr. 23, 2018

Subsequent Events (Textual)

Subsequent event, description

The Company designated 4,000 shares of preferred stock as Series I. The Series I will have a stated value of $1,000 per share, and will be entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of.

Shares issued

100,000

Description of common stock shares authorized

The Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 to 16,000,000,000.

Shares issued per share

$ 1,000

Subsequent Event [Member]

Subsequent Events (Textual)

Subsequent event, description

The Company designated 2,000 shares of preferred stock as Series O. The Series O have a stated value of $1,000 per share, and are entitled to cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O will not be entitled to any voting rights except as may be required by applicable law. The Series O be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends.

Shares issued

500

295,141

Shares issued per share

$ 1,000

Outstanding common stock ownership percentage

4.99%

Subsequent Event [Member] | Convertible Promissory Notes [Member]

Subsequent Events (Textual)

Aggregate principal and interest amount

$ 94,164

Aggregate shares of common stock

2,767,510

Subsequent Event [Member] | Consultants And One Employee [Member]

Subsequent Events (Textual)

Shares issued to consultants and one employee

1,147,928

Restricted Stock Grant Agreement [Member]

Subsequent Events (Textual)

Subsequent event, description

The Company entered into Restricted Stock Grant Agreements (the “April RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, three members of the Board and five consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the April RSGAs are performance based shares and none have yet vested nor have any been issued. The April RSGAs provide for the issuance of up to an aggregate of 90,000,000 shares of the Company’s common stock as follows: 30,000,000 to the CEO, 5,000,000 to each of the other three members of the Board and an aggregate of 45,000,000 to five consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 45,000,000 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 45,000,000 shares of its common stock

Restricted Stock Grant Agreement [Member] | Subsequent Event [Member]

Subsequent Events (Textual)

Subsequent event, description

The Company entered into Restricted Stock Grant Agreements (the “May RSGAs”) with its Chief Executive Officer, T. Riggs Eckelberry, members of the Board, employees and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGAs are performance based shares and none have yet vested nor have any been issued. The May RSGAs provide for the issuance of up to an aggregate of 10,500,000 shares of the Company’s common stock as follows: 2,000,000 to Mr. Eckelberry, 500,000 to each of the other three members of the Board, and an aggregate of 7,000,000 to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 5,250,000 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 5,250,000 shares of its common stock. As the performance goals are achieved or if alternate vesting is qualified and selected, the shares shall become eligible for vesting and issuance.

PPP Loan [Member] | Subsequent Event [Member]

Subsequent Events (Textual)

Aggregate principal and interest amount

$ 345,000

Common Stock [Member]

Subsequent Events (Textual)

Aggregate principal and interest amount

$ 396,173

Aggregate shares of common stock

700,389,733

Shares issued to consultants and one employee

237,636,726

Series I Preferred Stock [Member]

Subsequent Events (Textual)

Aggregate shares sold

345

Aggregate purchase price

$ 345,000

Series L Preferred Stock [Member] | Subsequent Event [Member]

Subsequent Events (Textual)

Aggregate shares of common stock

875,238

Shares issued

580

Aggregate shares sold

425

1,160

Aggregate purchase price

$ 1,159,767

Aggregate converted shares

42.5

Series E Preferred Stock [Member] | Subsequent Event [Member]

Subsequent Events (Textual)

Aggregate converted shares

102,436

Adjusted reverse split common stock

30,124

Series M Preferred Stock [Member] | Subsequent Event [Member]

Subsequent Events (Textual)

Aggregate shares of common stock

137,052

Aggregate shares sold

3,904

Aggregate purchase price

$ 97,600

Aggregate converted shares

320

Series D One Preferred Stock [Member] | Subsequent Event [Member]

Subsequent Events (Textual)

Shares issued

6,000,000